FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:64 January 5, 1995 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: The recent polemics concerning the study of the National Surgical Adjuvant Breast and Bowel Project (NSABP) have been followed closely by oncologists, including those outside the United States. If anything, the matter proves that quality-assurance procedures are absolutely necessary in multicenter trials.

In your editorial (May 19 issue),¹ you say that the conclusions of the trial are unlikely to be altered. "Furthermore," you note, "a number of other studies, published after the reports from the NSABP, have come to the same conclusions." This sentence suggests that the NSABP study was the first to demonstrate that lumpectomy and . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.